aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Vynleads is dedicated to providing health and wellness information, with a specialized focus on managing type 2 diabetes. The company offers resources and guidance aimed at individuals who are prediabetic or have type 2 diabetes, a condition marked by high blood glucose levels due to insufficient insulin or the body's inefficient use of insulin. Vynleads aims to support middle-aged and older adults, as well as younger individuals, in managing their condition through informed lifestyle choices.
Vynleads has achieved significant milestones, including the SEC effectiveness announcement and graduating to the OTCQB Venture Market. The company has also established a Medical Advisory agreement with Dr. Erica Song and showcased its DWD Protocol at Dr. Oz’s Health Corps Gala in NYC. These accomplishments highlight Vynleads' commitment to advancing diabetes management and its growing impact in the health and wellness sector.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Health Information
Technology
Telemedicine
Tags
Healthtech
Model Types
Datainformation
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Vynleads founded?
Vynleads was founded in 2015.
Where is Vynleads’s headquarters located?
Vynleads’s headquarters is located in Rock Hill, US.
How many employees does Vynleads have?
Vynleads has 30 employees as of Feb 5, 2024.
Add Comparison
Total Employees Over Time
30
As of Feb 2024
Vynleads Address
596 Herrons Ferry Rd
suite 301
Rock Hill,
29730
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts